| __timestamp | Ligand Pharmaceuticals Incorporated | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 12122000 | 242549000 |
| Thursday, January 1, 2015 | 13380000 | 245098000 |
| Friday, January 1, 2016 | 21221000 | 147600000 |
| Sunday, January 1, 2017 | 26887000 | 264600000 |
| Monday, January 1, 2018 | 27863000 | 357900000 |
| Tuesday, January 1, 2019 | 55908000 | 1182600000 |
| Wednesday, January 1, 2020 | 59392000 | 357700000 |
| Friday, January 1, 2021 | 69012000 | 540100000 |
| Saturday, January 1, 2022 | 36082000 | 322900000 |
| Sunday, January 1, 2023 | 24537000 | 408000000 |
Unlocking the unknown
In the competitive world of biotechnology, innovation is the lifeblood of success. United Therapeutics Corporation and Ligand Pharmaceuticals Incorporated are two prominent players in this field, each with a distinct approach to research and development (R&D) investment. From 2014 to 2023, United Therapeutics consistently outpaced Ligand Pharmaceuticals in R&D spending, investing nearly 12 times more on average. In 2019, United Therapeutics reached a peak, allocating over 1.18 billion dollars, a staggering 300% increase from its 2014 expenditure. Meanwhile, Ligand Pharmaceuticals saw a more modest growth, with its highest investment in 2021, reaching approximately 69 million dollars. This disparity highlights United Therapeutics' aggressive strategy to lead in innovation, while Ligand Pharmaceuticals adopts a more conservative approach. As the biotech industry continues to evolve, these investment trends may shape the future landscape of medical breakthroughs.
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
United Therapeutics Corporation vs Exelixis, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: United Therapeutics Corporation vs Xenon Pharmaceuticals Inc.
United Therapeutics Corporation vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Veracyte, Inc.
R&D Spending Showdown: Genmab A/S vs Ligand Pharmaceuticals Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Intra-Cellular Therapies, Inc. and Ligand Pharmaceuticals Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Summit Therapeutics Inc. and Ligand Pharmaceuticals Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Ligand Pharmaceuticals Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Pharming Group N.V. and Ligand Pharmaceuticals Incorporated
Comparing Innovation Spending: Veracyte, Inc. and Ligand Pharmaceuticals Incorporated
R&D Insights: How Protagonist Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated Allocate Funds